4Bibby D C, Davies N M, Tucker I G. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems [J]. Int J Pharm, 2000, 197: 1.
5Hirayarna F, Uekama K. Cyclodextrin - based controlled drug release system [J]. Adv Drug Deliv Rev, 1999, 36: 125.
6Wang Z, Himyama F, Uekarna K. Design and in vitro evaluations of a modified - release oral dosage form of nifidipine by hybridization of hydroxypmpyl - β - cyclodextrins and hydroxypropyl cellulose [J]. J Pharm Pharmacol, 1993, 45:942.
7Okimoto K, Rajewsi R A, Uekama K, et al. The interaction of charged and uncharged drugs with neutral ( HP - β - CD) and anionically charged (SBE7 - β - CD) β - cyclodextrin [J]. Pharm Res, 1996, 13:256.
8Okimoto K, Ohike A, Ibuki R, et al. Factors affecting membrane - controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m - β - CD as both a solubilizer and osmotic agent [J]. J Control Release, 1999,60:311.
9Okimoto K, Rajewski R A, Stella V J. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m - β - cyclodextrin as both a solubilizing and an osmotic pump agent [J]. J Control Release, 1999, 58 (1): 29.
